| Product NDC: | 0338-1009 | 
| Proprietary Name: | Dopamine Hydrochloride and Dextrose | 
| Non Proprietary Name: | Dopamine Hydrochloride | 
| Active Ingredient(s): | 320 mg/100mL & nbsp; Dopamine Hydrochloride | 
| Administration Route(s): | INTRAVENOUS | 
| Dosage Form(s): | INJECTION, SOLUTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0338-1009 | 
| Labeler Name: | Baxter Healthcare Corporation | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA019615 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 20120125 | 
| Package NDC: | 0338-1009-02 | 
| Package Description: | 250 mL in 1 BAG (0338-1009-02) | 
| NDC Code | 0338-1009-02 | 
| Proprietary Name | Dopamine Hydrochloride and Dextrose | 
| Package Description | 250 mL in 1 BAG (0338-1009-02) | 
| Product NDC | 0338-1009 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Dopamine Hydrochloride | 
| Dosage Form Name | INJECTION, SOLUTION | 
| Route Name | INTRAVENOUS | 
| Start Marketing Date | 20120125 | 
| Marketing Category Name | NDA | 
| Labeler Name | Baxter Healthcare Corporation | 
| Substance Name | DOPAMINE HYDROCHLORIDE | 
| Strength Number | 320 | 
| Strength Unit | mg/100mL | 
| Pharmaceutical Classes | Catecholamine [EPC],Catecholamines [Chemical/Ingredient] |